Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

Healthcare Cannabis
THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

THC Biomed Intl Ltd
Bullboard Posts
User Avatar Image
(85)
•••
Comment by RamboIsMIAon Nov 25, 2019 8:06pm
70 Views
Post# 30391496

RE:RE:RE:RE:Anyone got an answer from the company ?

RE:RE:RE:RE:Anyone got an answer from the company ?Bang on walter and Thank you for your services willie. You are free now. Swim away far far away.
williemaze wrote:
Walterthedog wrote: It's pretty simple really. The sector is on shakey ground as the reality of a way smaller than expected market and huge oversupply are apparent. The company is trading at roughly book value as are many others. There isn't much revenue to speak of and this is why he is releasing both Y2019 and Q1 together. Obviously year end 2019 is unimpressive and Q1 2020 has something to give us hope. Releasing dismal financials in this climate is suicide so thank god Miller is releasing both on the same day and hopefully there are something close to 1M$ and a small loss on the books for Q1. That should at least keep the wolves at bay and demonstrate how important THCs financial restraint is going to be in producing actual profits.


Based on previous quarters and trends I'd estimate around $350K.  $1Million makes no sense and is totally arbitrary based on a dream or a wish. Not logic. Sorry that's not how it works



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities